Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
apn-1607 (2 trials)
111in-dota-h11b6 (1 trial)
131 i-omburtamab (1 trial)
[18f]mni-444 (1 trial)
asn51 (1 trial)
florbetapir (Amyvid) (1 trial)
Florzolotau (2 trials)
mni-1054 (2 trials)
mni-1126 (1 trial)
pf-06412562 (1 trial)
ucb-2897 (1 trial)
cannabis (1 trial)
Alzheimer Disease (Phase 2)
Cognitive Dysfunction (Phase 2)
Neoplasm Metastasis (Phase 1)
Parkinson Disease (Phase 1)
Prostatic Neoplasms (Phase 1)
Prostatic Neoplasms, Castration-Resistant (Phase 1)
Supranuclear Palsy, Progressive (Phase 1)
Trials (15 total)
Trial APIs (12 total)